首页> 外文期刊>Current Directions in Biomedical Engineering >Construction of a novel microfluidic experimental setup for testing recent glaucoma drainage devices : Current Directions in Biomedical Engineering
【24h】

Construction of a novel microfluidic experimental setup for testing recent glaucoma drainage devices : Current Directions in Biomedical Engineering

机译:一种新型的微流控实验装置的构建,以测试最近的青光眼引流装置:生物医学工程的最新方向

获取原文
       

摘要

Glaucoma is an eye disorder in which the optic nerve is damaged over time due to a sustained elevation of the intraocular pressure (IOP). Being the second leading cause of blindness according to the reports of the World Health Organization, glaucoma is not only a serious ocular disease that threatens individuals, but also a community health problem. In recent years, great improvement has been achieved in the technology of implants used in the treatment of the disease. Despite the great effort dedicated to the design and implementation of the glaucoma drainage devices (GDD), they still have unsolved problems and weaknesses. Most of the currently employed GDDs are very simple and have major problems such as reversed flow, choking and a coarse interval of pressure control. Experiments must be devised to investigate the flow behavior inside these devices. In this study, an accurate microfluidics experimental setup is constructed to analyze and characterize the in-vitro performance of actively employed GDDs on the glaucoma treatment. Proposed setup includes a pressurized fluid reservoir, ELVEFLOW microfluidics flow rate measurement/control unit, microfluidics flow/pressure sensors, and data analysis system. In the setup, more precise measurements than experimental setups in literature is planned to be provided. It is estimated that the results showing consistency with in-vivo measurements will be obtained, behavior of the fluid passing through the GDDs will be observed and issues with design flaws will be addressed.
机译:青光眼是一种眼疾,由于持续升高的眼内压(IOP),视神经会随着时间的流逝而受损。根据世界卫生组织的报告,青光眼是导致失明的第二大原因,它不仅是威胁个人的严重眼病,也是社区健康问题。近年来,在用于治疗该疾病的植入物技术上已经取得了很大的进步。尽管付出了巨大的努力来设计和实施青光眼引流装置(GDD),但它们仍存在未解决的问题和不足。当前使用的大多数GDD非常简单,并且存在主要问题,例如逆流,阻塞和压力控制的粗略间隔。必须设计实验来研究这些设备内部的流动行为。在这项研究中,构建了一个准确的微流控实验装置,以分析和表征积极使用的GDD在青光眼治疗中的体外表现。拟议的设置包括加压流体储罐,ELVEFLOW微流体流速测量/控制单元,微流体流速/压力传感器和数据分析系统。在设置中,计划提供比文献中的实验设置更精确的测量。据估计,将获得与体内测量结果一致的结果,将观察通过GDD的流体的行为,并解决设计缺陷的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号